Imunon, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chem…
$0.63-1.22%
报价 2026-11-13
市值
$3.5M
EV
$7.7M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -85.0%
$0.63$4.18
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| IMNNImunon, Inc. | $3.5M | -1.2% | -62.5% | 0% | – | – | – | |
| CINGCingulate Inc. | $62.5M | -4.2% | -87.1% | 0% | – | – | – | |
| DWTXDogwood Therapeutics, Inc. | $42.4M | -0.9% | +128700.0% | -4.8% | – | – | – | |
| COCPCocrystal Pharma, Inc. | $18.9M | -1.0% | -100.0% | 0% | – | – | – | |
| MRKRMarker Therapeutics, Inc. | $14.5M | -3.3% | -12.9% | -320.8% | – | – | – | |
| BOLTBolt Biotherapeutics, Inc. | $11.7M | +2.9% | -66.1% | 95.7% | – | – | – | |
| CLRBCellectar Biosciences, Inc. | $11.4M | -1.7% | -74.7% | 0% | – | – | – | |
| AEONAEON Biopharma, Inc. | $7.6M | -3.6% | +1258.3% | 0% | – | – | – | |
| TRAWOnconova Therapeutics, Inc. | $3.9M | -11.9% | -89.3% | 0% | – | – | – | |
| 同行中位数 | – | – | -70.4% | 0% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。